Background:Inflammation, a crucial defense mechanism of the immune system, seeks
to safeguard and restore tissue equilibrium in response to tissue damage or infection by pathogens.
Key indicators of inflammation include redness, discomfort, swelling, warmth, and impaired
function. However, unmanaged inflammation can lead to serious health issues.Objective:The aim of this research work is to perform docking studies to find out the potent antiinflammatory
activity of various moieties (Schiff bases, hydrazones, and amino acid) derivatives,
which are attached to C-8 of 7-hydroxy-4-methyl coumarins. Also, the synthesized compounds
were characterized and their pharmacological evaluation (in-vitro and in-vivo study) was conducted.Methods:Lipinski's Rule of Five assessed drug-likeness for each designed molecule. Molecular
docking with COX-2 protein was conducted using AutoDock vina to identify the highest-scoring
molecule. Various novel coumarin derivatives, which include Schiff bases, hydrazone, and amino
acid derivatives (F, G, and H, respectively) were prepared by inserting the formyl group at the C-
8 position of 7- hydroxy-4-methyl coumarin. At first, the docking studies were performed against
2AZ5 and 5KIR receptors to find the activity against inflammation. Also, the compounds with the
best dock scores were synthesized and elucidated by FT-IR, 1H- NMR, and Mass spectroscopy.
Moreover, a series of novel derivatives were screened in in-vitro and in-vivo to evaluate the potent
anti-inflammatory activity.Results:All the novel derivatives, which were synthesized have been found to show potent antiinflammatory
activity by in-vitro and in-vivo evaluation. Among all the derivatives, compound F1
showed the highest inhibitory effect against TNF-α and COX-2 enzymes.Conclusion:Our result exhibited potential anti-inflammatory activity of the novel coumarin
compounds, especially the substituted anilines and amino acids at C8 of the coumarin moiety,
which works against TNF- α and COX-2 enzyme.